Clinical Trial Update: A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase II study evaluating whether minocycline combined with armodafinil reduces symptom burden during chemoradiation for esophageal cancer; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Armodafinil (armodafinil)
• Minocycline (minocycline)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-06-06